Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.33 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.32 |
| ▸ | DRD2 | P14416 | 3/20 | 0.32 |
| ▸ | DRD3 | P35462 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1934266 | 1.00 | GRM2 (0.41) | GRM2TSHRHSD17B10CYP2A6HRH3 | |
| SCHEMBL10640644 | 0.96 | TSHR (0.44) | GRM2TSHRHSD17B10CYP2A6HRH3 | |
| SCHEMBL1934965 | 0.96 | GRM2 (0.46) | GRM2TSHRHSD17B10CYP2A6HRH3 | |
| SCHEMBL4650784 | 0.96 | GRM2 (0.46) | GRM2TSHRHSD17B10CYP2A6HRH3 | |
| SCHEMBL9556017 | 0.95 | GRM2 (0.39) | GRM2TSHRHSD17B10CYP2A6HRH3 | |
| SCHEMBL9556014 | 0.95 | GRM2 (0.39) | GRM2TSHRHSD17B10CYP2A6HRH3 | |
| SCHEMBL11290099 | 0.94 | GRM2 (0.48) | GRM2TSHRHSD17B10CYP2A6HRH3 | |
| SCHEMBL9362811 | 0.94 | GRM2 (0.48) | GRM2TSHRHSD17B10CYP2A6HRH3 | |
| SCHEMBL9362814 | 0.94 | GRM2 (0.48) | GRM2TSHRHSD17B10CYP2A6HRH3 | |
| SCHEMBL8975343 | 0.94 | GRM2 (0.48) | GRM2TSHRHSD17B10CYP2A6HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5172256-A | Liquid crystal variable color density lens and eye protective devices incorporating the same | LIQUID CRYSTAL OPTICS INSTITUTE, INC. | 1992-12-15 | — | — | US | claimed |
| US-4364838-A | Liquid crystal mixtures | HOFFMANN-LA ROCHE INC. (US) | 1982-12-21 | — | — | US | claimed |
| EP-2511318-B1 | METHOD FOR PRODUCING CONJUGATED POLYMER | FUJIFILM CORP (JP) | 2018-02-21 | — | — | EP | disclosed |
| US-9449732-B2 | Charge transport film, method for producing the same, and light-emitting element and photoelectric conversion element using the same | FUJIFILM CORPORATION (JP) | 2016-09-20 | — | — | US | disclosed |
| EP-2511318-A1 | METHOD FOR PRODUCING CONJUGATED POLYMER | FUJIFILM Corporation (JP) | 2012-10-17 | — | — | EP | disclosed |
| US-20120241326-A1 | METHOD OF PREPARING CONJUGATED POLYMER | FUJIFILM CORPORATION (JP) | 2012-09-27 | — | — | US | disclosed |
| US-20120238774-A1 | CHARGE TRANSPORT FILM, METHOD FOR PRODUCING THE SAME, AND LIGHT-EMITTING ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME | FUJIFILM CORPORATION (JP) | 2012-09-20 | — | — | US | disclosed |
| US-7335404-B2 | Liquid crystal composition for use in bistable liquid crystal devices | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-02-26 | — | — | US | disclosed |
| US-7335404-B2 | Liquid crystal composition for use in bistable liquid crystal devices | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-02-26 | — | — | US | disclosed |
| US-7294368-B2 | Liquid crystal composition for use in bistable liquid crystal devices | MERCK PATENT GMBH (DE) | 2007-11-13 | — | — | US | disclosed |
| US-7294368-B2 | Liquid crystal composition for use in bistable liquid crystal devices | MERCK PATENT GMBH (DE) | 2007-11-13 | — | — | US | disclosed |
| EP-0074608-A2 | Liquid crystal halogen compounds, process for their preparation, dielectric and dectrooptical display element containing them | MERCK PATENT GmbH (DE) | 1983-03-23 | — | — | EP | disclosed |
| US-4364838-A | Liquid crystal mixtures | HOFFMANN-LA ROCHE INC. (US) | 1982-12-21 | — | — | US | disclosed |
| US-4356104-A | LIQUID CRYSTALS, ELECTROOPTICAL DISPLAY | TIMEX CORPORATION (US) | 1982-10-26 | — | — | US | disclosed |
| US-4335012-A | LIQUID CRYSTALS | TIMEX CORPORATION (US) | 1982-06-15 | — | — | US | disclosed |
| US-4335012-A | LIQUID CRYSTALS | TIMEX CORPORATION (US) | 1982-06-15 | — | — | US | disclosed |
| US-4325830-A | Three ring dioxane liquid crystalline compounds | TIMEX CORPORATION (US) | 1982-04-20 | — | — | US | disclosed |
| US-4322354-A | 5-Substituted-2-(4-cyanophenyl)-1,3,-dioxanes | TIMEX CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| US-4322354-A | 5-Substituted-2-(4-cyanophenyl)-1,3,-dioxanes | TIMEX CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| US-4313878-A | LIQUID CRYSTALS | TIMEX CORPORATION (US) | 1982-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238774-A1 | CHARGE TRANSPORT FILM, METHOD FOR PRODUCING THE SAME, AND LIGHT-EMITTING ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME | PCTP, CDH1, PLTP | GRM2 2589/4885TSHR 4347/4885HSD17B10 3518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.